PortfoliosLab logoPortfoliosLab logo
INVA vs. ANIP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INVA vs. ANIP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innoviva, Inc. (INVA) and ANI Pharmaceuticals, Inc. (ANIP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INVA achieves a 4.90% return, which is significantly higher than ANIP's 0.38% return. Over the past 10 years, INVA has outperformed ANIP with an annualized return of 5.03%, while ANIP has yielded a comparatively lower 2.65% annualized return.


INVA

1D
-1.18%
1M
-6.01%
6M
4.85%
YTD
4.90%
1Y
12.56%
3Y*
16.22%
5Y*
8.14%
10Y*
5.03%
ALL TIME*
1.79%

ANIP

1D
-1.48%
1M
-7.89%
6M
-3.19%
YTD
0.38%
1Y
23.95%
3Y*
15.99%
5Y*
18.49%
10Y*
2.65%
ALL TIME*
-3.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$19.71M$22.85M$27.70M
$12.98M$16.47M$18.69M

INVA vs. ANIP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INVA
Innoviva, Inc.
4.90%15.22%8.17%21.06%-23.19%39.23%-12.50%-18.85%22.97%32.62%
ANIP
ANI Pharmaceuticals, Inc.
0.38%42.80%0.25%37.06%-12.70%58.68%-52.91%36.98%-30.15%6.32%

Correlation

The correlation between INVA and ANIP is 0.30, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.30

Correlation (3Y)
Balances recent behavior with more history.

0.31

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.28

Correlation (10Y)
Provides a long-term view across more market conditions.

0.31

Correlation (All Time)
Calculated using the full available price history since Oct 5, 2004

0.24

Fundamentals

Market Cap

INVA:

$1.55B

ANIP:

$1.80B

EPS

INVA:

$5.93

ANIP:

$4.21

PE Ratio

INVA:

3.54

ANIP:

18.81

PEG Ratio

INVA:

0.02

ANIP:

0.13

PS Ratio

INVA:

4.20

ANIP:

1.83

PB Ratio

INVA:

1.23

ANIP:

3.04

Total Revenue (TTM)

INVA:

$424.12M

ANIP:

$923.71M

Gross Profit (TTM)

INVA:

$323.16M

ANIP:

$486.11M

EBITDA (TTM)

INVA:

$438.91M

ANIP:

$234.71M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INVA vs. ANIP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

INVA
INVA Risk / Return Rank: 6161
Overall Rank
INVA Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
INVA Sortino Ratio Rank: 6060
Sortino Ratio Rank
INVA Omega Ratio Rank: 5757
Omega Ratio Rank
INVA Calmar Ratio Rank: 6262
Calmar Ratio Rank
INVA Martin Ratio Rank: 6363
Martin Ratio Rank

ANIP
ANIP Risk / Return Rank: 6565
Overall Rank
ANIP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
ANIP Sortino Ratio Rank: 6969
Sortino Ratio Rank
ANIP Omega Ratio Rank: 6464
Omega Ratio Rank
ANIP Calmar Ratio Rank: 6565
Calmar Ratio Rank
ANIP Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

INVA vs. ANIP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innoviva, Inc. (INVA) and ANI Pharmaceuticals, Inc. (ANIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INVAANIPDifference
Sharpe ratioReturn per unit of total volatility

-0.18

Sortino ratioReturn per unit of downside risk

-0.34

Omega ratioGain probability vs. loss probability

1.12

1.16

-0.04

Calmar ratioReturn relative to maximum drawdown

0.76

0.88

-0.12

Martin ratioReturn relative to average drawdown

1.78

1.52

+0.26

INVA vs. ANIP - Sharpe Ratio Comparison

The current INVA Sharpe Ratio is 0.53, which is comparable to the ANIP Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of INVA and ANIP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INVA vs. ANIP - Drawdown Comparison

The maximum INVA drawdown since its inception was -84.32%, smaller than the maximum ANIP drawdown of -98.81%. Use the drawdown chart below to compare losses from any high point for INVA and ANIP.


Loading charts...

Drawdown Indicators


INVAANIPDifference

Max Drawdown

Largest peak-to-trough decline

-84.32%

-98.81%

+14.49%

Max Drawdown (1Y)

Largest decline over 1 year

-20.32%

-28.66%

+8.34%

Max Drawdown (3Y)

Largest decline over 3 years

-23.53%

-28.66%

+5.13%

Max Drawdown (5Y)

Largest decline over 5 years

-47.01%

-59.38%

+12.37%

Max Drawdown (10Y)

Largest decline over 10 years

-59.57%

-72.96%

+13.39%

Current Drawdown

Current decline from peak

-34.43%

-82.39%

+47.96%

Average Drawdown

Average peak-to-trough decline

-44.61%

-79.41%

+34.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.69%

16.56%

-7.87%

Volatility

INVA vs. ANIP - Volatility Comparison

The current volatility for Innoviva, Inc. (INVA) is 6.96%, while ANI Pharmaceuticals, Inc. (ANIP) has a volatility of 8.46%. This indicates that INVA experiences smaller price fluctuations and is considered to be less risky than ANIP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INVAANIPDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.96%

8.46%

-1.50%

Volatility (6M)

Calculated over the trailing 6-month period

18.49%

21.66%

-3.17%

Volatility (1Y)

Calculated over the trailing 1-year period

29.31%

35.64%

-6.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.44%

46.26%

-18.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.55%

48.10%

-14.55%

Dividends

INVA vs. ANIP - Dividend Comparison

Neither INVA nor ANIP has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ANIP
ANI Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
INVA
Innoviva, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%7.12%

Financials

INVA vs. ANIP - Financials Comparison

This section allows you to compare key financial metrics between Innoviva, Inc. and ANI Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


INVA and ANIP have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANIP has higher volatility (8.46%) compared to INVA (6.96%). In terms of maximum drawdown, INVA dropped -84.32% vs ANIP's -98.81%.

ANIP currently has the higher Sharpe Ratio (0.71 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INVA and ANIP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer